Walvax
Yunnan Watson Biotechnology Co., Ltd. is a modern biopharmaceutical company specializing in the research and manufacture
Yunnan Watson Biotechnology Co., Ltd. is a modern biopharmaceutical company specializing in the research and manufacture The company was listed on the GEM Board of China Shenzhen Stock Exchange in November 2010 (stock abbreviation: Watson Bio; stock code: 300142).
Tsingke Biotechnology: More Opportunities in the International Market of Gene Synthesis
‘Globalization is the only way to the development of the industry. It is more conducive to the rapid progress of the industry for domestic enterprises to compete with well-known overseas enterprises.’
Yesterday 02:13 PM
Watson biology: 13 valent pneumococcal polysaccharide conjugate vaccine has been licensed in Morocco
Opportunities and Challenges Hidden in the CGT Industry in China
CGT (Cell and Gene Therapy) is a sector with high growth potential. CAR-T, as one of the main CGT currently, presents great value for both doctors and patients. This article showcases the industry pain points and opportunities faced in the CAR-T sub-sector.
Jan 17, 2023 05:48 PM
Watson biology: Yuxi Watson plans to invest in the production and capacity expansion project of polysaccharide conjugate vaccine, with a total investment of 695 million yuan
Medical stocks continued to decline in the afternoon, with dongfulong falling more than 15%
Back to Hong Kong, Chinese concept stocks rose collectively, and Wanguo data rose 17.5%